Related references
Note: Only part of the references are listed.Recombinant protein production in bacterial hosts
Tim W. Overton
DRUG DISCOVERY TODAY (2014)
Bacterial cell factories for recombinant protein production; expanding the catalogue
Neus Ferrer-Miralles et al.
MICROBIAL CELL FACTORIES (2013)
Production of biopharmaceutical proteins by yeast Advances through metabolic engineering
Jens Nielsen
BIOENGINEERED (2013)
Bacterial expression systems for recombinant protein production: E. coli and beyond
Rachel Chen
BIOTECHNOLOGY ADVANCES (2012)
Metabolic engineering of recombinant protein secretion by Saccharomyces cerevisiae
Jin Hou et al.
FEMS YEAST RESEARCH (2012)
Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements
Chung-Jr Huang et al.
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2012)
Production of Secretory and Extracellular N-Linked Glycoproteins in Escherichia coli
Adam C. Fisher et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Production of recombinant proteins and metabolites in yeasts
Danilo Porro et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
N-Linked Glycosylation of Antibody Fragments in Escherichia coli
Christian Lizak et al.
BIOCONJUGATE CHEMISTRY (2011)
Improving N-Glycosylation Efficiency in Escherichia coli Using Shotgun Proteomics, Metabolic Network Analysis, and Selective Reaction Monitoring
Jagroop Pandhal et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
What's fueling the biotech engine-2010 to 2011
Saurabh Aggarwal
NATURE BIOTECHNOLOGY (2011)
Overcoming barriers to membrane protein structure determination
Roslyn M. Bill et al.
NATURE BIOTECHNOLOGY (2011)
Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide
Diane Boyhan et al.
PLANT BIOTECHNOLOGY JOURNAL (2011)
Biopharmaceutical benchmarks 2010
Gary Walsh
NATURE BIOTECHNOLOGY (2010)
Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin
Chandrasekhar Gurramkonda et al.
MICROBIAL CELL FACTORIES (2010)
Production of glycoprotein vaccines in Escherichia coli
Julian Ihssen et al.
MICROBIAL CELL FACTORIES (2010)
MARKET WATCH Sales of biologics to show robust growth through to 2013
Michael Goodman
NATURE REVIEWS DRUG DISCOVERY (2009)
Microbial factories for recombinant pharmaceuticals
Neus Ferrer-Miralles et al.
MICROBIAL CELL FACTORIES (2009)
Dictyostelium discoideum-a promising expression system for the production of eukaryotic proteins
Ranjana Arya et al.
FASEB JOURNAL (2008)
Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies
Sudhir Sahdev et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Modifications of therapeutic proteins: challenges and prospects
Nigel Jenkins
CYTOTECHNOLOGY (2007)
Expression of porcine circovirus 2 ORF2 gene requires codon optimized E-coli cells
Maria Trundova et al.
VIRUS GENES (2007)
Protocol for preparing proteins with improved solubility by co-expressing with molecular chaperones in Escherichia coli
Ario de Marco
NATURE PROTOCOLS (2007)
Post-translational modifications in the context of therapeutic proteins
Gary Walsh et al.
NATURE BIOTECHNOLOGY (2006)
Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems
M Wacker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds
CL Nykiforuk et al.
PLANT BIOTECHNOLOGY JOURNAL (2006)
Recombinant protein production in yeasts
D Porro et al.
MOLECULAR BIOTECHNOLOGY (2005)
Therapeutic insulins and their large-scale manufacture
G Walsh
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Multiple gene copy number enhances insulin precursor secretion in the yeast Pichia pastoris
M Mansur et al.
BIOTECHNOLOGY LETTERS (2005)
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli
MF Feldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The humanization of N-glycosylation pathways in yeast
S Wildt et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Evaluation of bottlenecks in proinsulin secretion by Escherichia coli
FJM Mergulhao et al.
JOURNAL OF BIOTECHNOLOGY (2004)
The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin
S Havelund et al.
PHARMACEUTICAL RESEARCH (2004)
Advances in the production of human therapeutic proteins in yeasts and filamentous fungi
TU Gerngross
NATURE BIOTECHNOLOGY (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Production of recombinant thermostable proteins expressed in Escherichia coli:: completion of protein synthesis is the bottleneck
HP Sorensen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Role of molecular chaperones in inclusion body formation
MM Carrió et al.
FEBS LETTERS (2003)
N-linked glycosylation in Campylobacter jejuni and its functional transfer into E-coli
M Wacker et al.
SCIENCE (2002)
High-yield production of a human therapeutic protein in tobacco chloroplasts
JM Staub et al.
NATURE BIOTECHNOLOGY (2000)
Yeast secretory expression of insulin precursors
T Kjeldsen
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2000)
Share Paper
